Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Researchers unlock key secrets showing how tumors hide from immune system


In one of the biggest advances to come from the H. Lee Moffitt Cancer Center & Research Institute in its 16-year history, researchers have unlocked at least part of the mystery of how tumors flourish undetected by keeping their presence a secret from sentries of the body’s immune system.

"Flying beneath the radar" is how Nature Reviews Cancer ( labels the mechanism of tumors evading capture, a process described by Hua Yu, Ph.D., and her colleagues at Moffitt and the University of South Florida College of Medicine. Their findings are published in the current issue of the journal Nature Medicine.

"Cancer is allowed to wreak havoc on the body’s immune system because it knows how to fool the body’s defensive arsenal," explains Jack Pledger, Ph.D., Associate Center Director for Basic Science and Professor of Biochemistry at USF. "The discoveries of Dr. Yu give us vital information about how tumors stay ’invisible.’ It opens the way for new treatments to help flush the cancer cells into the open, so the body’s armies against disease can destroy them."

Yu is an Associate Professor in the USF Department of Medical Microbiology and Immunology and the Immunology Program at Moffitt. Her coauthors on the study include Drew Pardoll, M.D., Ph.D., from the Johns Hopkins University School of Medicine, together with Richard Jove, Ph.D., and William Dalton, Ph.D., M.D., both from Moffitt and USF. Other authors include Tianhong Wang, Ph.D.., Guilian Niu, Ph.D., Lyudmila Burdelya, Ph.D., and Marcin Kortylewski, Ph.D. The study is titled "Regulation of the innate and adaptive immune responses by Stat3 signaling in tumor cells."

The researchers documented that the tumor’s activation of Stat3 (from the STAT family of proteins that regulates genes) secretes factors that inhibit the body’s immune responses by keeping dendritic cells from maturing. The activation also blocks expression of inflammatory mediators required to trigger the immune system.

Other ongoing research at Moffitt related to Stat3 includes using microarray technology to study the characteristic gene expression profiles or "molecular signatures" of certain genes that are regulated by the STAT. Scientists suspect that many genes that are directly or indirectly regulated by Stat3 may contribute to cancer, and they are working to develop new drugs based on inhibiting Stat3 for more effective treatment of breast cancer, prostate cancer, sarcoma, melanoma and other tumors that harbor aberrantly activated Stat3.

Andrea Brunais | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

Im Focus: Radar for navigation support from autonomous flying drones

At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.

Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

International Virtual Reality Conference “IEEE VR 2018” comes to Reutlingen, Germany

08.03.2018 | Event News

Latest News

Wandering greenhouse gas

16.03.2018 | Earth Sciences

'Frequency combs' ID chemicals within the mid-infrared spectral region

16.03.2018 | Physics and Astronomy

Biologists unravel another mystery of what makes DNA go 'loopy'

16.03.2018 | Life Sciences

Science & Research
Overview of more VideoLinks >>>